Skip to main content
Caplight Logo









Cellply

Cellply

Private
BolognaHealthcare & Life Scienceshttps://www.cellply.com/

Last Round

VC Round

Apr 23, 2026

Total Funding Raised

$8.33M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Cellply is a biotechnology company that develops analytical tools and platforms for the characterization of cancer immunotherapies and cell therapies at single-cell resolution.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

precision medicinemicrofluidicsdrug sensitivity testingfunctional oncologycancer therapy selectioncell therapy R&Dlab-on-a-chippersonalized cancer treatmenthigh-throughput screeningbiotech equipmentpatient-derived tumor cellsautomated cell analysismedtechdrug response profilingorgan-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellply Comparables

Compare Cellply with similar companies based on industry and business-model similarity.

Cellply comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Okomera
83%
2cureX
82%
Pear Bio
81%

Cellply Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 23, 2026
VC RoundSep 27, 2023
VC RoundDec 14, 2021
GrantAug 2, 2018
GrantMay 1, 2018
Grant
Oct 20, 2016

Key People

Founding team and executive leadership

Massimo Bocchi

Founder Chief Operating Officer

Founding Team

Cellply Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 8504% MoM, from 46 to 4K.

  • Apr 23, 2026

    $8.4M raised with ENEA-Tech and CDP Venture Capital.

Cellply Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellply Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellply's valuation, stock price, and market status.

Firmographic Details

HeadquartersBologna
Employee Range27
Year Founded2013
Last FundingApr 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?